LARIMAR THERAPEUTICS

Welcome to the Brand page for “LARIMAR THERAPEUTICS”, which is offered here for The mark consists of the stylized word larimar in black with a blue letter i above the word therapeutics in black; extending from the dot of the letter is s a curled ribbon in the colors blue, teal, and white; the remaining color white represents a transparent background which is not a feature of the mark.;pharmaceutical preparations for the treatment of mitochondrial disorders; pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of friedreich's ataxia; pharmaceutical preparations for protein replacement therapy;the color(s) black, white, blue and teal is/are claimed as a feature of the mark.;therapeutics;pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases;.

Its status is currently believed to be active. Its class is unavailable. “LARIMAR THERAPEUTICS” is believed to be currently owned by “Chondrial Therapeutics, Inc.”

Owner:
CHONDRIAL THERAPEUTICS, INC.
Owner Details
Description:
The mark consists of the stylized word Larimar in black with a blue letter i above the word Therapeutics in black; extending from the dot of the letter is s a curled ribbon in the colors blue, teal, and white; the remaining color white represents a transparent background which is not a feature of the mark.;Pharmaceutical preparations for the treatment of mitochondrial disorders; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy;The color(s) black, white, blue and teal is/are claimed as a feature of the mark.;THERAPEUTICS;Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases;
Categories: